Promethean BioPharma joins over-the-counter CBD race by Martin Lane November 30, 2023December 1, 2023 Promethean BioPharma has joined the race to register a Schedule 3, over-the-counter CBD medicine with a […]
Ecofibre becomes second company to confirm disappointing sleep trial results by Steve Jones January 30, 2023March 13, 2023
